Oculis Holding AG

"Category: Notifications issued to company members/nSub-category: Invitation to the General Meeting/nPublication date: SHAB 12.05.2025/nPublicly viewable until: 12.05.2026/nPublication number: UP04-0000007143/nPublishing entity/nVISCHER AG - MST, Aeschenvorstadt 4.

4010 Basel/nInvitation to the ordinary general meeting Oculis/nHolding AG/nOrganisation concerned:
/nOculis Holding AG/nCHE-396.695.611/nBahnhofstrasse 20/n6300 Zug/nGeneral meeting details:/n04.06.2025, 15.00 Uhr, Ochsen-Zug, Kolinplatz 11, CH-6300 Zug.

Switzerland/nInvitation/Agenda:
/nPlease refer to the attached PDF ""Invitation to the 2025 Annual General Meeting of/nShareholders"" of Oculis Holding AG. This document contains the agenda items, the/nproposals of the Board of Directors and additional information./nTo the Shareholders of Oculis Holding AG, in Zug.

SWITZERLAND/nInvitation to the 2025 Annual General Meeting of Shareholders/nDate:
4 June 2025.

at 3:
00 p.m. CEST / 9:00 a.m.

EDT/nPlace:
Ochsen-Zug, Kolinplatz 11, CH-6300 Zug.

Switzerland/nAGENDA ITEMS AND PROPOSALS OF THE BOARD OF DIRECTORS:
/n1. APPROVAL OF THE 2024 ANNUAL REPORT INCLUDING THE 2024 ANNUAL/n (STATUTORY) FINANCIAL STATEMENTS AND THE 2024 CONSOLIDATED/n FINANCIAL STATEMENTS/n The Board proposes the approval of the annual report including the annual financial/n statements for the business year 2024 and the consolidated financial statements for/n the business year 2024./n Explanation: Pursuant to Swiss law (art. 698 para. 2 no. 3 and 4 of the Swiss Code/n of Obligations (the ""CO"")) and our articles of association, the general meeting of the/n shareholders (the ""General Meeting"") resolves on the approval of the statutory/n financial statements and the consolidated financial statements. In its reports to the/n General Meeting, the Company's auditors, PricewaterhouseCoopers SA,/n recommend without qualification the approval of the Company's annual financial/n statements and consolidated financial statements. The 2024 Annual Report is/n available for download at https://investors.oculis.com/events-presentations./n 2. ALLOCATION OF BALANCE SHEET RESULTS 2024/n The Board proposes that the balance sheet loss of CHF 46'577'000 be carried/n forward to the new accounts./n Net loss for the business year 2024 CHF 5'179'000/n Accumulated loss brought forward CHF 46'577'000/n Explanation: Pursuant to Swiss law (art. 698 para. 2 no. 4 CO) and our articles of/n association, the General Meeting resolves on the allocation of the balance sheet/n results./n3. DISCHARGE TO THE MEMBERS OF THE BOARD OF DIRECTORS AND THE/n EXECUTIVE COMMITTEE/n The Board proposes that a full discharge be granted to all members of the Board of/n Directors and the Executive Committee for their activities in 2024./n Explanation: Pursuant to Swiss law (art. 698 para. 2 no. 7 CO) and our articles of/n association, the General Meeting resolves on the discharge to the members of the/n Board of Directors and the Executive Committee./n4. RE-ELECTION OF THE CHAIRPERSON AND THE OTHER MEMBERS OF THE/n BOARD OF DIRECTORS/n The term of office of the Chairperson and all members of the Board of Directors/n expires at the end of the 2025 Annual General Meeting. The Board of Directors/n proposes the re-election of the current members of the Board of Directors, including/n the Chairperson, each until the end of the 2026 Annual General Meeting./n4.1 Re-election of Anthony Rosenberg as Member and Chairperson of the Board/n of Directors/n 4.2. Re-election of Christina Ackermann/n 4.3. Re-election of Lionel Carnot/n 4.4. Re-election of Arshad M. Khanani/n 4.5. Re-election of Martijn Kleijwegt/n 4.6. Re-election of Geraldine O'Keeffe/n 4.7. Re-election of Riad Sherif/n 4.8. Re-election of Robert K.

Warner/n Explanation:
Pursuant to Swiss law (art. 698 para. 2 no. 2 and para. 3 no. 1 CO)/n and our articles of association, the General Meeting elects the Chairperson and the/n other members of the Board of Directors. The elections will be held on an individual/n basis./n5. RE-ELECTION OF THE MEMBERS OF THE COMPENSATION COMMITTEE/n The Board of Directors proposes the re-election of Christina Ackermann, Lionel/n Carnot and Robert K. Warner as members of the Compensation Committee, each/n until the end of the 2026 Annual General Meeting./n 5.1. Re-election of Christina Ackermann/n 5.2. Re-election of Lionel Carnot/n 5.3. Re-election of Robert K.

Warner/n Explanation:
Pursuant to Swiss law (art. 698 para. 3 no. 2 CO) and our articles of/n association, the General Meeting elects the members of the Compensation/n Committee. The elections will be held on an individual basis. The Board of Directors/n intends to re-appoint Christina Ackermann, subject to her re-election, as chairperson/n of the Compensation Committee./n6. RE-ELECTION OF THE AUDITORS/n The Board of Directors proposes to re-elect PricewaterhouseCoopers SA, in Pully,/n Switzerland, as the Company's statutory auditors for a term of office of one year./n Explanation: Pursuant to Swiss law (art. 698 para. 2 no. 2 CO) and our articles of/n association, the General Meeting elects the auditors. PricewaterhouseCoopers SA/n confirmed its independence required for this mandate./n7. RE-ELECTION OF THE INDEPENDENT PROXY/n The Board of Directors proposes to re-elect PST Legal AG, in Zug, Switzerland, as/n the Company's independent proxy until the end of the 2026 Annual General Meeting./n Explanation: Pursuant to Swiss law (art. 698 para. 3 no. 3 CO) and our articles of/n association, the General Meeting elects the independent proxy. PST Legal AG/n confirmed its independence required for this mandate./n8. COMPENSATION FOR THE NON-EXECUTIVE MEMBERS OF THE BOARD OF/n DIRECTORS/n8.1 Vote on Total Fixed (Non-Performance-Related) Compensation for Non-/n Executive Members of the Board of Directors until the end of the Company's/n 2026 Annual General Meeting/n The Board of Directors proposes the approval of a total maximum amount of fixed/n (non-performance-related) compensation for eight non-executive members of the/n Board of Directors for the period from the Company's 2025 Annual General Meeting/n to the Company's 2026 Annual General Meeting of USD 572'000./n 8.2. Vote on Equity or Equity Based Compensation for Non-Executive/n Members of the Board of Directors until the end of the Company's 2026/n Annual General Meeting/n The Board of Directors proposes the approval of the grant of options with share/n equivalent, shares or equity linked instruments for eight non-executive/n members of the Board of Directors for the period until the end of the Company's/n 2026 Annual General Meeting, with a then current maximum value of all equity/n or equity linked instruments of USD 2'150'000 (excluding employer social/n security and pension contributions)./n Explanation (agenda items 8.1 and 8.2): Pursuant to Swiss law (art. 698/n para. 3 no. 4 CO) and our articles of association, the General Meeting resolves/n on the approval of the maximum compensation of the Board of Directors/n broken down into fixed (non-performance related) compensation and the/n equity or equity-based compensation. Further information on the Company's/n compensation principles for the Board of Directors can be found in our articles/n of association and in the 2024 Compensation Report.

which is available for/n download at https:
//investors.oculis.com/events-presentations./n9. COMPENSATION FOR THE MEMBERS OF THE EXECUTIVE COMMITTEE/n 9.1. Vote on Fixed (Non-Performance-Related) Compensation for Members of/n the Executive Committee payable in 2026/n The Board of Directors proposes to approve a total maximum amount of fixed/n (non-performance-related) compensation for three members of the Executive/n Committee for the calendar year 2026 and payable in 2026 of USD 2'478'240./n 9.2. Vote on variable Compensation for Members of the Executive Committee/n payable in 2026/n The Board of Directors proposes to approve "